Added to YB: 2026-02-03
Pitch date: 2026-01-31
ABT [bullish]
Abbott Laboratories
+2.71%
current return
Author Info
Compounding Dividends writes a newsletter about dividend investing. Sign up for the newsletter.
Company Info
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.
Market Cap
$197.0B
Pitch Price
$109.23
Price Target
N/A
Dividend
2.22%
EV/EBITDA
17.62
P/E
30.45
EV/Sales
4.57
Sector
Health Care Equipment and Supplies
Category
growth
Stock Idea: Abbott Laboratories
ABT: Diversified healthcare giant with 54-yr dividend streak facing headwinds from legal liabilities (NEC lawsuits), pricing pressure on nutrition products, declining COVID testing demand. Stock down 15% YTD to 52-week low, 2.4% yield. Strong moat in diagnostics/devices, acquiring Exact Sciences for $21B. Risks include GLP-1 drug impact, China pricing pressure.
Read full article (7 min)